Table 1: HNC sites of the study population (n=41)
|
HNC Site |
Percentage |
|
Larynx |
41,5 |
|
Esophagus |
9,8 |
|
Tongue |
4,9 |
|
Nose |
4,9 |
|
Face |
7,3 |
|
Mouth |
19,5 |
Regarding the use of tracheostomy, 43.9% of the patients were using this device, being more prevalent in laryngeal cancer (76.5%).